Q2 2026 CRO Activity and Intel Report

This report offers an in-depth analysis of the contract research organization (CRO) industry, categorized by geography, therapeutic area, and phase of development for Q2 2026.

Scope

• The Q2 2026 CRO Activity and Intel report offers insights into CRO and sponsor activity, clinical trial trends, and geographical performance across various therapeutic areas.

Reasons to Buy

• This report will enable the user to answer the following questions:
• What are the trends by region, therapy area, sites by CROs for the past quarter?
• Who was the most active CRO in the past quarter?
• Who were the most active sponsors by market cap in the past quarter?
• What was the most widely studied therapy area in the past quarter vs. the previous quarter?
• By region, who had the most clinical trials initiated in the past quarter?
• By region, what were the Q1 2026 CRO invitations and appointments?